169 related articles for article (PubMed ID: 12544451)
1. Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism.
Neves MF; Virdis A; Schiffrin EL
J Hypertens; 2003 Jan; 21(1):189-98. PubMed ID: 12544451
[TBL] [Abstract][Full Text] [Related]
2. Spironolactone improves angiotensin-induced vascular changes and oxidative stress.
Virdis A; Neves MF; Amiri F; Viel E; Touyz RM; Schiffrin EL
Hypertension; 2002 Oct; 40(4):504-10. PubMed ID: 12364354
[TBL] [Abstract][Full Text] [Related]
3. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice.
Virdis A; Neves MF; Amiri F; Touyz RM; Schiffrin EL
J Hypertens; 2004 Mar; 22(3):535-42. PubMed ID: 15076159
[TBL] [Abstract][Full Text] [Related]
4. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling.
Pu Q; Neves MF; Virdis A; Touyz RM; Schiffrin EL
Hypertension; 2003 Jul; 42(1):49-55. PubMed ID: 12782645
[TBL] [Abstract][Full Text] [Related]
5. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
6. Small artery mechanics in hyperhomocysteinemic mice: effects of angiotensin II.
Neves MF; Endemann D; Amiri F; Virdis A; Pu Q; Rozen R; Schiffrin EL
J Hypertens; 2004 May; 22(5):959-66. PubMed ID: 15097236
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
[TBL] [Abstract][Full Text] [Related]
8. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.
Brassard P; Amiri F; Schiffrin EL
Hypertension; 2005 Sep; 46(3):598-606. PubMed ID: 16043661
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
Minas JN; Thorwald MA; Conte D; Vázquez-Medina JP; Nishiyama A; Ortiz RM
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1178-88. PubMed ID: 26234762
[TBL] [Abstract][Full Text] [Related]
10. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma.
Diep QN; El Mabrouk M; Cohn JS; Endemann D; Amiri F; Virdis A; Neves MF; Schiffrin EL
Circulation; 2002 May; 105(19):2296-302. PubMed ID: 12010913
[TBL] [Abstract][Full Text] [Related]
11. PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation.
Diep QN; Amiri F; Touyz RM; Cohn JS; Endemann D; Neves MF; Schiffrin EL
Hypertension; 2002 Dec; 40(6):866-71. PubMed ID: 12468571
[TBL] [Abstract][Full Text] [Related]
12. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL
Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913
[TBL] [Abstract][Full Text] [Related]
13. Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition.
Virdis A; Colucci R; Neves MF; Rugani I; Aydinoglu F; Fornai M; Ippolito C; Antonioli L; Duranti E; Solini A; Bernardini N; Blandizzi C; Taddei S
Eur Heart J; 2012 Sep; 33(17):2225-34. PubMed ID: 21606076
[TBL] [Abstract][Full Text] [Related]
14. ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats.
Park JB; Schiffrin EL
Hypertension; 2001 Jun; 37(6):1444-9. PubMed ID: 11408393
[TBL] [Abstract][Full Text] [Related]
15. Effect of neonatal sympathectomy on the development of structural vascular changes in angiotensin II-treated rats.
Simon G; Csiky B
J Hypertens; 1998 Jan; 16(1):77-84. PubMed ID: 9533420
[TBL] [Abstract][Full Text] [Related]
16. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
Pu Q; Touyz RM; Schiffrin EL
J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651
[TBL] [Abstract][Full Text] [Related]
17. Structural vascular changes in hypertension: role of angiotensin II, dietary sodium supplementation, blood pressure, and time.
Simon G; Illyes G; Csiky B
Hypertension; 1998 Oct; 32(4):654-60. PubMed ID: 9774359
[TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries.
Cousin M; Custaud MA; Baron-Menguy C; Toutain B; Dumont O; Guihot AL; Vessières E; Subra JF; Henrion D; Loufrani L
Hypertension; 2010 Jan; 55(1):109-15. PubMed ID: 19948989
[TBL] [Abstract][Full Text] [Related]
19. Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report.
Resch M; Schmid P; Amann K; Fredersdorf S; Weil J; Schach C; Birner C; Griese DP; Kreuzer P; Brunner S; Luchner A; Riegger GA; Endemann DH
Cardiovasc Diabetol; 2011 Oct; 10():94. PubMed ID: 22008236
[TBL] [Abstract][Full Text] [Related]
20. Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension.
Zeng ZH; Luo BH; Gao YJ; Su CJ; He CC; Yi JJ; Li N; Lee RM
Eur J Pharmacol; 2004 Oct; 503(1-3):129-33. PubMed ID: 15496307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
